Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,543 | -22,599 | -14,120 | -3,594 | -33,641 |
| Depreciation Amortization | 194 | 144 | 95 | 47 | 180 |
| Income taxes - deferred | 576 | 432 | 288 | 144 | 576 |
| Accounts payable and accrued liabilities | 1,762 | 1,914 | 1,560 | 372 | -112 |
| Other Working Capital | -4,006 | -3,880 | -1,410 | -2,623 | 240 |
| Other Operating Activity | 4,957 | 1,729 | 909 | 829 | 4,396 |
| Operating Cash Flow | $-29,060 | $-22,260 | $-12,677 | $-4,824 | $-28,361 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,830 | 13,830 | 31 | N/A | N/A |
| Financing Cash Flow | $13,830 | $13,830 | $31 | $N/A | $N/A |
| Beginning Cash Position | 41,712 | 41,712 | 41,712 | 41,712 | 70,073 |
| End Cash Position | 26,481 | 33,282 | 29,066 | 36,887 | 41,712 |
| Net Cash Flow | $-15,231 | $-8,430 | $-12,646 | $-4,824 | $-28,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,060 | -22,260 | -12,677 | -4,824 | -28,361 |
| Free Cash Flow | -29,060 | -22,260 | -12,677 | -4,824 | -28,361 |